Tianjin Chase Sun Pharmaceutical Co Ltd
300026
Company Profile
Business description
Tianjin Chase Sun Pharmaceutical Co Ltd is a high-tech medicine and health industry group. The company offers Chinese herb preparation products, medicinal granules, synthetic drugs, biotech drugs, medical apparatus, and Internet-based therapy.
Contact
No. 20, Quanfa Road
Tianjin Wuqing Development Area
Tianjin301700
CHNT: +86 2259623169
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
5,297
Stocks News & Analysis
stocks
Fair value downgraded for ASX heavyweight
Our capital allocation rating was also lowered due to balance sheet weakness.
stocks
ChatGPT enters the retail space and one company surges
Investors cheer the ability to purchase directly from ChatGPT.
stocks
Alibaba fair value increases by 49%
Stronger-than-expected AI demand internationally and domestically.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,135.90 | 19.50 | -0.21% |
| CAC 40 | 7,895.94 | 15.07 | 0.19% |
| DAX 40 | 23,880.72 | 135.66 | 0.57% |
| Dow JONES (US) | 46,397.89 | 81.82 | 0.18% |
| FTSE 100 | 9,350.43 | 50.59 | 0.54% |
| HKSE | 26,855.56 | 232.68 | 0.87% |
| NASDAQ | 22,660.01 | 68.86 | 0.30% |
| Nikkei 225 | 44,932.63 | 111.12 | -0.25% |
| NZX 50 Index | 13,316.45 | 24.09 | 0.18% |
| S&P 500 | 6,688.46 | 27.25 | 0.41% |
| S&P/ASX 200 | 8,848.80 | 20.50 | -0.23% |
| SSE Composite Index | 3,882.78 | 20.25 | 0.52% |